LAP3 and skin basal cell carcinoma: Other potential events, like the inhibition of ligand–receptor activity in the BCC, the inhibition of proteasome activity in the PG, and the activation of hydrolase and peptidase activity in the BCC, were also identified in the transcriptomes.